Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Abbott Laboratories
ABT
$103.87
Name : Abbott Laboratories
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $179,896,778,752.00
EPSttm : 2.68
finviz dynamic chart for ABT
Abbott Laboratories
$103.87
0.58%
$0.61
ABT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.11

Margin Of Safety %

20

Put/Call OI Ratio

0.59

EPS Next Q Diff

-0.19

EPS Last/This Y

0.37

EPS This/Next Y

0.42

Price

103.87

Target Price

120.21

Analyst Recom

1.58

Performance Q

-10.87

Upside

-42.7%

Beta

0.53

Ticker: ABT




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-21ABT100.580.651.15250603
2026-10-22ABT102.530.660.76257680
2026-10-23ABT103.720.650.52262437
2026-10-26ABT104.890.600.55238986
2026-10-27ABT103.130.600.71244616
2026-10-28ABT102.70.600.34248188
2026-10-29ABT104.570.600.35249113
2026-10-30ABT106.240.600.23250379
2026-11-02ABT110.260.590.22235631
2026-11-03ABT109.410.580.55239723
2026-11-04ABT115.550.580.18244363
2026-11-05ABT113.610.570.68250981
2026-11-06ABT109.940.580.73255084
2026-11-09ABT110.490.590.91250939
2026-11-10ABT110.460.600.70252597
2026-11-11ABT109.350.600.55254061
2026-11-12ABT107.260.591.15254800
2026-11-13ABT108.510.601.62256698
2026-11-16ABT107.510.610.66253450
2026-11-17ABT104.860.610.20254132
2026-11-18ABT104.490.600.92255441
2026-11-19ABT103.980.590.78256983
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-21ABT102.758.82820.55.52
2026-10-22ABT102.598.84074.35.52
2026-10-23ABT103.698.83978.25.52
2026-10-26ABT104.899.33866.35.52
2026-10-27ABT103.139.23595.25.52
2026-10-28ABT102.689.23716.45.52
2026-10-29ABT104.579.23936.65.52
2026-10-30ABT106.319.23915.85.52
2026-11-02ABT110.299.24127.65.52
2026-11-03ABT109.439.24049.55.52
2026-11-04ABT115.579.24302.35.52
2026-11-05ABT113.559.23379.55.52
2026-11-06ABT109.969.23105.95.52
2026-11-09ABT110.529.23465.45.52
2026-11-10ABT110.469.23409.25.52
2026-11-11ABT109.389.23320.25.52
2026-11-12ABT107.279.23236.95.52
2026-11-13ABT108.539.23528.05.52
2026-11-16ABT107.519.23324.95.52
2026-11-17ABT104.769.23174.75.52
2026-11-18ABT104.499.23393.95.52
2026-11-19ABT103.879.23358.45.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-21ABT-3.21-1.360.79
2026-10-22ABT-3.21-1.360.79
2026-10-23ABT-3.21-1.360.79
2026-10-26ABT-3.21-1.990.79
2026-10-27ABT-3.21-1.991.01
2026-10-28ABT-3.23-1.991.01
2026-10-29ABT-3.31-1.991.01
2026-10-30ABT-3.31-1.991.01
2026-11-02ABT-3.31-1.861.01
2026-11-03ABT-3.31-1.861.01
2026-11-05ABT-3.31-1.861.01
2026-11-06ABT-3.31-1.861.01
2026-11-09ABT-3.33-0.951.01
2026-11-10ABT-3.33-0.951.01
2026-11-11ABT-3.33-0.951.11
2026-11-12ABT-3.33-0.951.11
2026-11-13ABT-3.33-0.951.11
2026-11-16ABT-3.33-0.291.11
2026-11-17ABT-3.33-0.291.11
2026-11-18ABT-3.33-0.291.11
2026-11-19ABT-3.33-0.291.11
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

1.42

Avg. EPS Est. Current Quarter

1.64

Avg. EPS Est. Next Quarter

1.23

Insider Transactions

-3.33

Institutional Transactions

-0.29

Beta

0.53

Average Sales Estimate Current Quarter

13208

Average Sales Estimate Next Quarter

12568

Fair Value

124.24

Quality Score

78

Growth Score

82

Sentiment Score

13

Actual DrawDown %

27.2

Max Drawdown 5-Year %

-39.6

Target Price

120.21

P/E

38.38

Forward P/E

17.53

PEG

2.17

P/S

3.73

P/B

3.53

P/Free Cash Flow

26.65

EPS

2.71

Average EPS Est. Cur. Y​

5.52

EPS Next Y. (Est.)

5.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.8

Relative Volume

0.82

Return on Equity vs Sector %

-17.3

Return on Equity vs Industry %

-1.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

3358.4
◆ ABT Healthcare
$103.96
📉
Swing / Pullback
Buy the dip on strong trends
56 /100
WATCH
Trend
6/20
Pullback
19/25
Volume
7/15
Valuation
18/20
TP/AR
1/10
Options
5/10
RSI
43.9
Range 1M
31.8%
Sup Dist
0.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
22 /100
WEAK
Momentum
3/25
Growth
9/30
Estimates
5/20
Inst/Vol
0/15
Options
5/10
EPS Yr
7.2%
EPS NY
7.5%
52W%
45.7%
💎
Long-Term Value
Quality companies, undervalued
33 /100
WEAK
🟡 HOLD +21.8% upside
Quality
7/30
Valuation
13/30
Growth
6/25
Stability
5/10
LT Trend
2/5
Upside
+21.8%
Quality
78
MoS
20%
ABT — P/E HistoricalMedical Devices
Abbott Laboratories
Sector: Healthcare
Industry: Medical Devices
Employees: 122000
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
ABT

Latest News

—
Caricamento notizie per ABT…
stock quote shares ABT – Abbott Laboratories Stock Price stock today
news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025
marketwatch ABT – Abbott Laboratories yahoo finance google finance
stock history ABT – Abbott Laboratories invest stock market
stock prices ABT premarket after hours
ticker ABT fair value insiders trading